ZZ-B 📈 Zinzino AB Series B - Overview

Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0002480442

ZZ-B: Supplements, Skincare, Coffee, Health, Nutrition, Wellness

Zinzino AB (publ), a direct sales company, provides dietary supplements and skincare products in Sweden and internationally. Its skincare products include cleansers, face creams, serums, and masks. The company also offers coffee, coffee machines, accessories, and cups and glasses; immune, omega, and restore supplements; weight management products; gut health supplements; and home health tests products. It sells its products through online. The company was founded in 2005 and is based in Västra Frölunda, Sweden. Web URL: https://www.zinzino.com

Additional Sources for ZZ-B Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

ZZ-B Stock Overview

Market Cap in USD 323m
Sector Consumer Defensive
Industry Packaged Foods
GiC Sub-Industry Packaged Foods & Meats
IPO / Inception

ZZ-B Stock Ratings

Growth 5y 65.9%
Fundamental 75.4%
Dividend 79.9%
Rel. Strength Industry 224
Analysts -
Fair Price Momentum 88.64 SEK
Fair Price DCF 153.99 SEK

ZZ-B Dividends

Dividend Yield 12m 3.64%
Yield on Cost 5y 14.79%
Annual Growth 5y 28.47%
Payout Consistency 97.6%

ZZ-B Growth Ratios

Growth Correlation 3m -50.4%
Growth Correlation 12m 73.3%
Growth Correlation 5y 48.3%
CAGR 5y 33.01%
CAGR/Mean DD 5y 1.04
Sharpe Ratio 12m 1.09
Alpha 21.61
Beta 1.10
Volatility 36.45%
Current Volume 71.9k
Average Volume 20d 39.4k
What is the price of ZZ-B stocks?
As of December 22, 2024, the stock is trading at SEK 84.90 with a total of 71,886 shares traded.
Over the past week, the price has changed by -4.18%, over one month by +1.60%, over three months by -2.60% and over the past year by +43.97%.
Is Zinzino AB Series B a good stock to buy?
Yes, based on ValueRay Fundamental Analyses, Zinzino AB Series B (ST:ZZ-B) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 75.43 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ZZ-B as of December 2024 is 88.64. This means that ZZ-B is currently overvalued and has a potential downside of 4.41%.
Is ZZ-B a buy, sell or hold?
Zinzino AB Series B has no consensus analysts rating.
What are the forecast for ZZ-B stock price target?
According to ValueRays Forecast Model, ZZ-B Zinzino AB Series B will be worth about 98.8 in December 2025. The stock is currently trading at 84.90. This means that the stock has a potential upside of +16.38%.
Issuer Forecast Upside
Wallstreet Target Price 97 14.3%
Analysts Target Price - -
ValueRay Target Price 98.8 16.4%